Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic saline for non-cystic fibrosis bronchiectasis
ACTRN12607000367448Phase 4Completed
- Sponsor
- The Alfred Hospital
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of hypertonic saline in bronchiectasis (2 arms), sponsored by The Alfred Hospital. Primary endpoint: Pulmonary exacerbations. Started Dec 2007; status: completed.
02
Drugs
hypertonic saline
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on ACTRN12607000367448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000367448.